Red Dot™ 2660-3Recalls & reported problems
3m Company · 3M™ Red Dot™ Repositionable Monitoring Electrode 2660-3, 3/BG 200 BGS/CS 72/PLT · Class 2
All models of Red Dot (14)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10707387507838), received between Jan 24, 2024 and Jan 24, 2024 — classified as 1 injury.
The most frequently reported specific device problem is “Human-Device Interface Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Human-Device Interface Problem1
Patient problems
- Burn(s)1
- Erythema1
- Pain1
- Peeling1
- Scar Tissue1
- Skin Inflammation/ Irritation1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJan 24, 2024Human-Device Interface Problem; Human-Device Interface Problem
A PATIENT ALLEGEDLY EXPERIENCED BURNS, SCARRING, SKIN DISCOLORATION, IRRITATION, PAIN, ERYTHEMA, AND RED PEELING SKIN WITH THE USE OF THE 3M¿ RED DOT¿ REPOSITIONABLE MONITORING ELECTRODES. THE PATIENT HAD A HOLTER MONITOR FOR 1 WEEK STARTING ON (B)(6) 2023. FOUR ELECTRODES WERE APPLIED TO THE CHEST AND WERE CHANGED EVERY OTHER DAY. ON (B)(6) 2023 THE PATIENT OBSERVED THE SYMPTOMS AND THE PATIENT'S PHYSICIAN REFERRED HER TO A DERMATOLOGIST. ON THE SAME DAY, (B)(6) 2023, THE DERMATOLOGIST ADMINISTERED PRESCRIBED CLOBETASOL PROP 0.05% CREAM AND STEROID METHYLPREDNISOLONE 4 MG WHICH REPORTEDLY HELPED THE REDNESS AND THE PAIN THAT HAD LASTED FOR 2 WEEKS. THE PATIENT IS ALSO USING AQUAPHOR ON THE SCARS WHICH ARE REPORTEDLY NOT GOING AWAY.
Patient problems: Burn(s); Erythema; Pain; Peeling; Scar Tissue; Skin Inflammation/ Irritation
MAUDE report 18576470 ↗
Other Electrode, electrocardiograph devices
- Vermed A10091-30Graphic Controls Acquisition Corp · Electrode, Electrocardiograph132 reports
- 3M™ 22283m Company · Electrode, electrocardiograph2 recalls0 reports
- 3M™ Red Dot™ 22283m Company · Electrode, electrocardiograph1 recall4 reports
- Vital Signs™ 2464AAO-20AirLife Finland Oy · Electrode, electrocardiograph51 reports
- Vermed IP-Set M5 RT Adult-USGraphic Controls Acquisition Corp · Electrode, Electrocardiograph1 recall0 reports
- Vermed IP-Set 5V RT Adult-USGraphic Controls Acquisition Corp · Electrode, Electrocardiograph1 recall0 reports
- Vermed IP-Set 6V RT ADULT-USGraphic Controls Acquisition Corp · Electrode, Electrocardiograph1 recall0 reports
- Vermed IP-Set 12 RT Adult-USGraphic Controls Acquisition Corp · Electrode, Electrocardiograph1 recall0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page